Wealth Management Partners’s CVS Health CVS Stock Holding History

Wealth Management Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,824	Closed	-$226K	–	114
2024 Q2	$226K	Sell	3,824 -5,900	-61%	-$369K	0.11%	100
2024 Q1	$776K	Sell	9,724 -1,378	-12%	-$105K	0.39%	54
2023 Q4	$877K	Buy	11,102 +401	+4%	+$28.5K	0.49%	47
2023 Q3	$747K	Buy	10,701 +1,039	+11%	+$73.6K	0.47%	47
2023 Q2	$668K	Buy	9,662 +818	+9%	+$58.2K	0.42%	52
2023 Q1	$657K	Buy	8,844 +4,844	+121%	+$406K	0.46%	48
2022 Q4	$393K	Sell	4,000 -1,000	-20%	-$96.5K	0.33%	66
2022 Q3	$446K	Hold	5,000	–	–	0.39%	56
2022 Q2	$445K	Sell	5,000 -1,000	-17%	-$97.6K	0.39%	55
2022 Q1	$582K	Hold	6,000	–	–	0.41%	53
2021 Q4	$618K	Sell	6,000 -345	-5%	-$31.9K	0.42%	54
2021 Q3	$538K	Sell	6,345 -1,203	-16%	-$101K	0.4%	55
2021 Q2	$630K	Buy	7,548 +950	+14%	+$77.8K	0.44%	56
2021 Q1	$491K	Buy	6,598 +789	+14%	+$57.5K	0.37%	63
2020 Q4	$431K	Buy	+5,809	New	+$378K	0.34%	66

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wealth Management Partners's CVS Position: Q3 2024 in Review

Wealth Management Partners sold out of CVS Health (CVS) in Q3 2024, closing a stake of 3,824 shares — an estimated $226K sold.

Wealth Management Partners first reported a position in CVS in Q4 2020 and held it in 15 quarters. The position peaked at $877K in Q4 2023. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Wealth Management Partners reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Wealth Management Partners sold 3,824 CVS Health shares in Q3 2024, an estimated $226K.
Wealth Management Partners first reported a position in CVS Health in Q4 2020 and held it in 15 quarters.
Wealth Management Partners's CVS Health position peaked at $877K in Q4 2023.
1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Wealth Management Partners's 13F filing for Q3 2024, filed 21 Oct 2024.